Hypoxia, a major inducer of angiogenesis, is known to trigger major changes of gene expression at the transcriptional level. Furthermore, global protein synthesis is blocked while internal ribosome entry sites (IRES) allow specific mRNAs to be translated. Here we report the transcriptome and translatome signatures of (lymph)angiogenic genes in hypoxic HL-1 cardiomyocytes: most genes are not induced at the transcriptome-, but at the translatome level, including all IRES-containing mRNAs. Our data reveal sequential activation of (lymph)angiogenic mRNA IRESs in early hypoxia. We identify vasohibin1 (VASH1) as an IRES trans-acting factor (ITAF) able to activate the earliest induced FGF1 IRES while it inhibits the other IRESs. Thus this new ITAF may have opposite effects on IRES activities in the steps of early hypoxia. These data suggest that IRESome composition varies at different stages of hypoxia, leading to sequential induction of (lymph)angiogenic factors required to form new functional vessels in ischemic heart.
INTRODUCTION
Hypoxia constitutes a major stress in different pathologies including cancer, as well as ischemic pathologies where artery occlusion leads to hypoxic conditions. In all these pathologies, hypoxia induces a cell response that stimulates angiogenesis to re-feed starved cells with oxygen and nutrients [1] . Recently it has been shown that lymphangiogenesis is also induced by hypoxia [2] . Hypoxia-induced (lymph)angiogenesis is mediated by strong modification of gene expression at both transcriptional and post-transcriptional levels [1, 3] . A major way of gene expression regulation is mediated at the transcriptional level by the hypoxia induced factor 1 (HIF1), a transcription factor stabilized by oxygen deprivation, that activates transcription from promoters containing hypoxia responsive elements (HRE) . One of the well-described HIF1 targets is vascular endothelial growth factor A (VEGFA), a major angiogenic factor [4, 5] . However, two other major angiogenic or lymphangiogenic growth factors, fibroblast growth factor 2 (FGF2) and VEGFC, respectively, are induced by hypoxia in a HIF-independent manner by a translational mechanism, indicating the importance of the post-transcriptional regulation of gene expression in this process [2, 6] . Translational control of gene expression plays a crucial role in the stress response. In particular, translation of most mRNAs, occurring by the classical cap-dependent mechanism, is silenced whereas alternative translation mechanisms allow enhanced expression of a small group of messengers involved in the control of cell survival [3, 7, 8] . One of the major alternative mechanisms able to overcome this global inhibition of translation by stress depends on internal ribosome entry sites (IRESs) that correspond to RNA structural elements allowing the direct recruitment of the ribosome on mRNA. As regards the molecular mechanisms of IRES activation by stress, several studies have reported the involvement of RNA binding proteins, called IRES trans-acting factors (ITAFs), able to stabilize the adequate RNA conformation allowing ribosome recruitment [9] [10] [11] [12] . Interestingly, subcellular relocalization of ITAFs plays a critical role in IRES-dependent translation [13] . Indeed, many RNA-binding proteins are known to shuttle between nucleus and cytoplasm, and it has been reported that cytoplasmic relocalization of ITAFs such as PTB, PCBP1, RBM4 or nucleolin is critical to activate IRESdependent translation [12, 13] . In contrast, other ITAFs such as hnRNPA1, may have a negative impact on IRES activity when accumulating in the cytoplasm [14] . However, how ITAFs participate in the regulation of the hypoxic response remains a challenging question to address. IRESs are present in the mRNAs of several (lymph)angiogenic growth factors in the FGF and VEGF families, suggesting that the IRES-dependent mechanism might be a major way to activate angiogenesis and lymphangiogenesis during stress [2, 12, [15] [16] [17] [18] . However, most studies of the role of hypoxia in gene expression regulation have been performed in tumoral hypoxia, while it has been reported that tumoral angiogenesis leads to formation of abnormal vessels that are non functional, which strongly differs from non tumoral angiogenesis that induces formation of functional vessels [19] . This suggests that gene expression regulation in response to hypoxia may be different in cancer versus ischemic pathologies. In particular, the role of IRESs in the control of gene expression in ischemic heart, the most frequent ischemic pathology, remains to be elucidated. Here we analyzed the transcriptome and the translatome of (lymph)angiogenic growth factors in hypoxic cardiomyocytes, and studied regulation of IRES activities in early and late hypoxia. Data show that in cardiomyocyte, (lymph)angiogenic growth factors are mostly regulated at the translational level. Interestingly, FGF and VEGF mRNA IRESs are sequentially activated at different times of early hypoxia in contrast to IRESs of non angiogenic messengers. We also looked for ITAFs governing IRES activation in hypoxia and identified vasohibin1 (VASH1) as a new ITAF specific of the earliest activated FGF1 IRES in cardiomyocytes. VASH1 knockdown strongly down-regulates the earliest-induced FGF1 IRES but not the other IRESs, revealing that this protein is a new IRES trans-acting factor (ITAF) in cardiomyocytes, specific of early hypoxia.
RESULTS

Most (lymph)angiogenic genes are not induced at the transcriptome level of hypoxic cardiomyocytes.
In order to analyze expression of angiogenic and lymphangiogenic growth factors in hypoxic cardiomyocytes, the HL-1 cell line was chosen: although immortalized, it keeps the beating phenotype specific to cardiomyocyte [20] . HL-1 cells were submitted to increasing times of hypoxia, from 5 minutes to 24 hours and their trancriptome was analyzed on a Fluidigm Deltagene PCR array targeting 96 genes of angiogenesis, lymphangiogenesis and/or stress ( Table 1 ). Data showed a significant increase of Vegfa, PAI-1 and apelin (Apln) mRNA levels, with a peak at 8h of hypoxia for Vegfa and PAI1 and 24h for Apln. These three genes are well described HIF1 targets [4, 21, 22] . However, only 5-8% of the genes were induced, while the mRNA levels of several major angio-or lymphangiogenic factors, such as FGF2 and VEGFC, were strongly decreased after 4h or 8h of hypoxia. These data indicate that the transcriptional response to hypoxia in cardiomyocytes is not the major mechanism controlling expression of (lymph)angiogenic factors, suggesting that post-transcriptional mechanisms are involved. mRNAs of most (lymph)angiogenic genes are recruited into polysomes in hypoxic cardiomyocytes. Based on the fact that mRNA present in polysomes are actively translated, we tested the hypothesis of translational induction by analysing the recruitment of mRNAs into polysomes. This experiment was performed in early hypoxia (4 hr). The polysome profile displayed, as expected, a strong decrease of global translation ( Fig. 2A) . In contrast, 94% of the genes of the (lymph)angiogenic array showed a more sustained recruitment into polysomes under hypoxic conditions (Fig. 2B , EV Table 2 ). This translational induction not only targets major angiogenic factors and their receptors (Vegfa, Fgf1, Pdgfa, Fgfr3, Kdr...) , but also genes involved in cardiomyocyte survival in ischemic heart (Igf1, Igf1R) or in inflammation (BAI1, Tgfb). These data suggest that in cardiomyocytes, the main response to early hypoxia of (lymph)angiogenic genes is not transcriptional, but translational.
IRES-containing mRNAs are more efficiently mobilized into polysomes under hypoxic conditions. IRES-dependent translation has been reported to drive translation of several mRNAs in stress conditions [2, 3, 6, 23 ]. Thus we focused onto the regulation of the different IRES-containing mRNAs present in the Fluidigm array (Fig. 3) . Interestingly, the only IRES-containing mRNA to be significantly induced at the transcriptome level by hypoxia was Vegfa (Fig. 3A and EV  Fig. 2) . Expression of the apelin receptor (Aplnr), presumably devoid of IRES, is also shown for comparison. Polysome recruitment of these IRES-containing mRNAs is shown in figure 3B . Clearly, Fgf1, Vegfa, Vegfd, Hif1a, Igf1r and Cyr61 mRNAs were recruited into polysomes under hypoxia 2 to 4 times more than in normoxia, suggesting an important induction in terms of translation. In contrast, Aplnr mRNA recruited into polysomes decreased about three times. The data are not available for Fgf2 and Vegfc mRNAs, which were not detectable. These results indicate that hypoxia in cardiomyocytes, although blocking global cap-dependent translation, induces translation of all detectable IRES-containing angiogenic factor mRNAs. This mechanism occurs as soon as 4 hours after oxygen deprivation, thus corresponding to an early event in the hypoxic response.
IRESs are sequentially activated during hypoxia. To confirm that the polysome recruitment of IRES-containing mRNAs actually corresponds to a stimulation of IRES-dependent translation, IRESs from FGF and VEGF mRNAs were introduced into a bicistronic dual luciferase gene expression cassette (Fig. 4A ). As controls, two IRESs from non angiogenic mRNAs, c-myc and EMCV IRESs, were used. The well established bicistronic vector strategy, previously validated by us and others, allows to measure IRES activity revealed by expression of the second cistron, LucF [2, 24] . The bicistronic cassettes were subcloned into lentivectors, as HL-1 cells are not efficiently transfected by plasmids but can be easily transduced by lentivectors with an efficiency of more than 80% (not shown). HL-1 cardiomyocytes were transduced by the different lentivectors and submitted to increasing times of hypoxia. Luciferase activities were measured from cell extracts and IRES activities reported as the LucF/LucR luminescence ratio. Results showed different IRES behaviors (Fig. 4B-D) . Clearly, the FGF1 and FGF2 IRESs were induced early, after 4 hours of oxygen deprivation (Fig. 4B) . The FGF1 IRES showed a peak at 4 hours, while the FGF2 IRES, even more moderately activated, displayed a sustained activity after 8 hours. In contrast, the four VEGF IRESs all peaked after 8 hours of hypoxia (Fig. 4C) . Finally, the c-myc and EMCV IRESs were activated only in late hypoxia after 24 hours (Fig. 4D ). These data provide two important information: first, IRESs from (lymph)angiogenic growth factor mRNAs are activated during early hypoxia, in contrast to other IRESs. Second, these "angiogenic" IRESs are sequentially activated during early hypoxia. The earliest wave concerns the FGF IRESs, especially FGF1 IRES, followed by a second wave of activation of the VEGF IRESs.
Identification of IRES-bound proteins in hypoxic cardiomyocytes reveals vasohibin1 as a new RNA-binding protein.
The sequential activation of the angiogenic factor IRESs in early hypoxia suggested that different ITAFs may be involved at 4 hours and at 8 hours. In an attempt to identify such ITAFs, we used the technology of biomolecular analysis coupled to mass spectrometry (BIA-MS), validated for ITAF identification in two previous studies [12, 25] . Biotinylated RNAs corresponding to FGF1 (4 hr activation), VEGFAa (8 hr activation) and EMCV IRESs (24h activation) were used as probes for BIA-MS. Hooked proteins from normoxic and hypoxic HL-1 cells were then recovered and identified ( Fig. 5A -B, EV Table 3) . Surprisingly, except for nucleolin bound to the VEGFA IRES in normoxia, no known ITAF was identified as bound to these IRESs in normoxia or in hypoxia. Interestingly, besides several proteins unrelated to (lymph)angiogenesis, we detected the presence of vasohibin1 (VASH1), a protein described as an endothelial cell-produced angiogenesis inhibitor, but also for its role in stress tolerance and cell survival [26, 27] (Fig. 5C ). However, this secreted protein has never been reported for any RNA-binding activity. VASH1 bound to the FGF1 IRES under hypoxia, but not under normoxia (EV Table 3 ). This protein also bound to the EMCV IRES both in normoxia and hypoxia but not to the VEGFA IRES, showing a selective binding depending on the IRES and the stress condition. In order to address the RNA binding potential of VASH1, we performed an in silico analysis of VASH1 protein sequence that predicted two conserved RNA-binding domains (RBD) in the N-and C-terminal parts of the full length protein, respectively (Fig. 5D , EV Fig. 3A and 3B ). The direct interaction of VASH1 with the FGF1 IRES was assessed by surface plasmon resonance using a recombinant protein containing the N-terminal predicted RBD1, resulting in the measurement of an affinity constant of 2.79 µM (Fig. 5E and 5F ). These data strongly suggest that the VASH1 predicted RBD1 exhibits an RNA binding activity, while it can be expected that the affinity would be reinforced in the presence of the C-terminal RBD.
Vasohibin1 is translationally induced and nuclearized in early hypoxia. VASH1 has been previously described for its expression in endothelial cells but never in cardiomyocytes [26] . The present BIA-MS study provides evidence that it is expressed in HL-1 cardiomyocytes (EV Table 3 ). We analyzed the regulation of VASH1 expression during hypoxia: Vash1 mRNA level strongly decreases after 4 hours of hypoxia whereas it is slightly upregulated after 8 hours (Fig. 1, EV Table 1, Fig. 6A ). In contrast, analysis of Vash1 mRNA recruitment into polysomes showed a strong increase at 4h of hypoxia (about 7 times), indicating that Vash1 mRNA translation is strongly induced (Fig. 2B, EV Table 2, Fig. 6B ).
VASH1 immunodetection confirmed a strong expression of VASH1 at 4h of hypoxia, despite the decrease of its mRNA. In normoxia, VASH1 appeared as a mainly cytoplasmic protein, with a perinuclear localization that could correspond to the endoplasmic reticulum (Fig. 6C) . In contrast, after 4h of hypoxia numerous foci of VASH1 appeared in the nucleus. Even though this result was unexpected, as VASH1 is described as a secreted protein, VASH1 nuclearization was however supported by the in silico identification of a fully conserved nuclear localization sequence (NLS) HVLKKVKLG (Fig. 5D , EV Fig. 3C and 3D ).
Vasohibin1 is a new ITAF selectively active in early hypoxia. The putative ITAF function of VASH1 was assessed by a knock-down approach using an siRNA smartpool (siVASH1). Transfection of HL-1 cardiomyocytes with siVASH1 was able to knock down VASH1 mRNA with an efficiency of 73% ( Fig. 7A and 7B ). The effect of VASH1 knock-down was analyzed in HL-1 cells transduced with different IRES-containing bicistronic lentivectors and submitted to 4h of hypoxia. The results showed that the FGF1 IRES activity decreases by 80% upon VASH1 knock-down under hypoxia, whereas the other IRESs where less drastically affected (Fig. 7C) . The EMCV IRES is slightly inhibited by the knockdown, in concordance with the ability of VASH1 to bind this IRES (EV Table 3 ). Interestingly, the FGF2, VEGFA, -C and D IRESs where stimulated, suggesting that VASH may also have an inhibitory effect. These data suggest that VASH1 is an ITAF active in early hypoxia (4 hours), required for activation of the FGF1 IRES, while showing an inhibitory effect on other tested growth factor IRES activities (Fig. 7D) . In order to evaluate the possibility of a wider role of VASH1 on translational control, the (lymph)angiogenic factor mRNA polysome profile was analyzed in siVASH1-treated HL-1 cells as in Figure 2 (EV Table 2 , right column). VASH1 knock-down decreased mobilization into polysomes of several IRES mRNAs including the Ffg1 and Igf1r mRNA, while it increased the recruitment other IRES-containing mRNAs, including Hif1a, Vegfa and Vegfd, in concordance with the data of Fig. 7 . A few mRNAs without a known IRES such as Apln, Cxcl10 or Hpse had also a strongly decreased polysome profile upon VASH1 depletion, suggesting a wide impact of VASH1, direct or indirect, on (lymph)-angiogenic growth factor translation control.
DISCUSSION
The present study highlights the crucial role of translational control in cardiomyocyte response to hypoxia. Up to now, although a few genes had been described for their translational regulation by hypoxia, it was thought that most genes are transcriptionally regulated. Here we show that translational control, revealed by mRNA recruitment in polysomes during hypoxia, concerns the majority of the genes involved in angiogenesis and lymphangiogenesis. IRESdependent translation appears as a key mechanism in this process, as we show that all the (lymph)angiogenic mRNAs known to contain an IRES are up-regulated. Furthermore, our data reveal that IRESs of angiogenic factor mRNAs are sequentially activated during early hypoxia. These waves of IRES activation indicate the involvement of different ITAFs, specific of these steps of early hypoxia. We have identified an angiogenesis-related protein, vasohibin1, as a new ITAF responsible for activation of the FGF1 IRES in the earliest wave of IRES activation.
Translational control in tumoral versus non tumoral hypoxia.
Most studies of gene expression in response to stress have been performed at the transcriptome level in tumoral cells of different origins, whereas the present study is focused on cardiomyocytes. HL-1 cardiomyocytes are immortalized but still exhibit the beating phenotype [20] . Thus this cell model, although not perfectly mimicking the cardiomyocyte behavior in vivo, is still close to a physiological state. The strong translational response to hypoxia revealed by our data, that differs from the transcriptional response usually observed in tumor cells, may reflect mechanisms occurring in cells that are not engaged into the cell transformation process leading to cancer, or at least not too far. Indeed, HL-1 cells respond to hypoxia very early, whereas various murine or human tumor cell lines described in other reports require a longer time of hypoxia for IRES-dependent translation to be stimulated. In human breast cancer BT474 cells, VEGFA, HIF and EMCV IRESs are all activated after 24h of hypoxia [28] . In murine 4T1 and LLC cells (breast and lung tumor, respectively) as well as in human CAPAN-1 pancreatic adenocarcinoma, the VEGFA and VEGFC IRESs are activated after 24 hours of hypoxia whereas the EMCV IRES is not activated [2] . The same observation of late activation in 4T1 cells has been made for the FGF1 IRES, while this IRES is activated after 4 hours in HL-1 cardiomyocytes (Godet AC & Prats AC, unpublished data) (Fig. 4) . Also, the VEGFD IRES is differently regulated in HL-1 cardiomyocytes compared to 4T1 tumor cells: only heat shock, but not hypoxia, is able to activate this IRES in 4T1 cells, whereas it is activated after 8 hours of hypoxia in HL-1 cardiomyocytes [12] (Fig. 4) . These observations suggest that many tumoral cell lines developing resistance to hypoxia are not able to govern subtle regulations of gene expression such as the waves of IRES regulation observed in HL-1 cells.
VASH1, an early hypoxic ITAF.
We also consider the hypothesis that the important process of translational regulation observed in our study may be cardiomyocyte-specific. In such a case, IRES-dependent translation would depend on cell type specific ITAFs as well as the early response to hypoxia. In agreement with this hypothesis, VASH1 expression is cell-type specific: described up to now as endothelialspecific, this protein is not expressed in tumoral cells [26] . In the present study, we show that this cell-type specificity extends to cardiomyocytes. Consistent with our data, this protein has been described as a key actor of striated muscle angio-adaptation [29] . VASH1 may thus have a role in the early hypoxic response in a limited number of cell types. The ITAF role of VASH1 identified here is physiologically relevant if one considers the VASH1 function in angiogenesis and stress tolerance [27] . Furthermore, it has been reported that VASH1 is induced after 3 hours of cell stress at the protein level but not at the transcriptional level in endothelial cells [30] . This is in agreement with our observation in cardiomyocytes where VASH1, although downregulated in the transcriptome at 4 hours of hypoxia, is more efficiently recruited in polysomes at the same time (Fig. 6 ). It is noteworthy that VASH1 itself seems to be induced translationally by stress [30] (Fig. 6) . In endothelial cells, Myashita et al report that the protein HuR upregulates VASH1 by binding to its mRNA. HuR may bind to an AU-rich element present in the 3' untranslated region of the VASH1 mRNA. However, in other studies, HuR has also been described as an ITAF, thus it is possible that VASH1 itself may be induced by an IRES-dependent mechanism [31, 32] . The anti-angiogenic function of VASH1 may appear inconsistent with its ability to activate the IRES of an angiogenic factor. However, our data also show that VASH1 might be an activator or an inhibitor for (lymph)angiogenic factor mRNA translation. Such a double role may explain the unique dual ability of VASH1 to inhibit angiogenesis and to promote endothelial cell survival [27, 30] . This could result from the existence of different VASH1 isoforms of 44 kDa, 42 kDa, 36 kDa, 32 kDa and 27 kDa, resulting from alternative splicing and/protein processing [29, [33] [34] [35] . Interestingly p42 and p27 are the main isoforms expressed in heart, while the p44 is undetectable [29, 34] . One can expect that the ITAF function is carried by p42 which contains the two predicted RNA binding domains as well as the conserved NLS (Fig.5D, EV Fig. 3 ). Nuclear VASH1 observed during hypoxia suggests that it could bind to the IRES in the nucleus, as described for other ITAFs [25, 36, 37] . Several reports show that ITAF shuttling between cytoplasm and nucleus is critical for their activity. Previous reports mainly describe ITAFs as nuclear proteins that are relocalized into cytoplasm to drive IRES-dependent translation, as shown for RBM4, PTB, PCBP1 and nucleolin [2, 13] . However cytoplasmic accumulation can also drive translation repression. This was demonstrated in the case of hnRNP A1 regulating the X-linked inhibitor of apoptosis IRES [14] . In normoxia, VASH1 is mostly cytoplasmic and secreted. We hypothesize that its ITAF activity may result from its nuclear relocalization under hypoxia to form the IRESome which is then exported from nucleus to cytoplasm to drive IRESdependent translation (Fig. 7D ).
IRESs as cis-acting regulons in the hypoxic response.
The different waves of IRES activation observed in the present study suggest that different subsets of IRESs function as cis-acting regulons during hypoxia. The concept of translational regulon has been revealed for the Hox gene family, whose mRNAs all contain IRESs that are regulated by ribosomal protein RPL38 [38] . Our data indicate that VASH1 participates in an IRESome able to activate the FGF1 IRES. We hypothesize that FGF1 might belong to a regulon of very early IRESs whereas the VEGF IRESs would constitute a regulon of mid-early IRESs. It is important to notice that the FGF2 IRES behaves differently from the FGF1 IRES, as it remains activated at 8 hours. The composition of these different IRESome complexes is still to be discovered.
MATERIALS & METHODS
Lentivector construction and production
Bicistronic lentivectors coding for the renilla luciferase (LucR) and the stabilized firefly luciferase Luc+ (called LucF in the text) were constructed from the dual luciferase lentivectors described previously, which contained Luc2CP [2, 12] . The cDNA sequences of the human FGF1, -2, VEGFA, -C, -D, c-myc and EMCV IRESs were introduced between the first (LucR) and the second cistron (LucF) [18, 39, 40] . The two IRESs of the VEGFA have been used and are called VEGFAa and VEGFAb, respectively [15] . The expression cassettes were inserted into the SIN lentivector pTRIP-DU3-CMV-MCS vector described previously [40] . All cassettes are under the control of the cytomegalovirus (CMV) promoter. Lentivector particles were produced using the CaCl2 method-based by tri-transfection with the plasmids pLvPack and pLvVSVg, CaCl2 and Hepes Buffered Saline (Sigma-Aldrich, SaintQuentin-Fallavier, France), into HEK-293FT cells. Viral supernatants were harvested 48 hours after transfection, passed through 0.45-µm PVDF filters (Dominique Dutscher SAS, Brumath, France) and stored in aliquots at -80°C until use. Viral production titers were assessed on HT1080 cells with serial dilutions and scored for GFP expression by flow cytometry analysis on a BD FACSVerse (BD Biosciences, Le Pont de Claix, France).
Cell culture, transfection and transduction HEK-293FT cells and HT1080 cells were cultured in DMEM-GlutaMAX + Pyruvate (Life Technologies SAS, Saint-Aubin, France), supplemented with 10% fetal bovine serum (FBS), and MEM essential and non-essential amino acids (Sigma-Aldrich). Mouse atrial HL-1 cardiomyocytes were a kind gift from Dr. William Claycomb (Department of Biochemistry & Molecular Biology, School of Medicine, New Orleans) [20] . HL-1 cells were cultured in Claycomb medium containing 10% FBS, Penicillin/Streptomycin (100U/mL100µg/mL), 0.1mM norepinephrine, and 2mM L-Glutamine. Cell culture flasks were precoated with a solution of 0.5% fibronectin and 0.02% gelatin 1h at 37°C (Sigma-Aldrich). To keep HL-1 phenotype, cell culture was maintained as previously described [20] . For hypoxia, cells were incubated at 37°C at 1%O2. HL-1 cardiomyocytes were transfected by siRNAs as follows: one day after being plated, cells were transfected with 10 nM of small interference RNAs from Dharmacon Acell SMARTpool targeting VASH1 (siVASH1) or non-targeting siRNA control (siControl), using Lipofectamine RNAiMax (Invitrogen) according to the manufacturer's recommendations, in a media without penicillin-streptomycin and norepinephrine. Cells were incubated 72h at 37°C with siRNA (siRNA sequences are provided in EV Table 5 ). For lentivector transduction, 6.10 4 HL-1 cells were plated into each well of a 6-well plate and transduced overnight in 1 mL of transduction medium (OptiMEM-GlutaMAX, Life Technologies SAS) containing 5 µg/mL protamine sulfate in the presence of lentivectors (MOI 2). GFP-positive cells were quantified by flow cytometry analysis on a BD FACSVerse (BD Biosciences). HL-1 cells were transduced with an 80% efficiency.
Reporter activity assay
For reporter lentivectors, luciferase activities in vitro and in vivo were performed using DualLuciferase Reporter Assay (Promega, Charbonnières-les-Bains, France). Briefly, proteins from HL-1 cells were extracted with Passive Lysis Buffer (Promega France). Quantification of bioluminescence was performed with a luminometer (Centro LB960, Berthold, Thoiry, France).
RNA purification and RT-qPCR
Total RNA extraction from ischemic and healthy areas was performed using TRIzol reagent according to the manufacturer's instructions (Gibco BRL, Life Technologies, NY, USA). RNA quality and quantification were assessed by a Xpose spectrophotometer (Trinean, Gentbrugge, Belgium) and an automated electrophoresis system (Fragment Analyzer, Advanced Analytical Technologies, Paris, France). 500 ng RNA was used to synthesize cDNA using a High-Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Villebon-sur-Yvette, France). Gene expression was investigated using HOT Pol Evagreen qPCR Mix PLus (Euromedex, France) and performed on a StepOne sequence detection system (Applied Biosystems). 18S rRNA was used as a reference gene and all data were normalized based on 18S rRNA level. Relative quantification (RQ) of gene expression was calculated using the 2 -ΔΔCT method. When the RQ value was inferior to 1, the fold change was expressed as -1/RQ. The oligonucleotide primers used are detailed in EV Table 4 .
qPCR array
The DELTAgene Assay TM was designed by Fluidigm Corporation (San Francisco, USA). The qPCR-array was performed on BioMark with the Fluidigm 96.96 Dynamic Array following the manufacturer's protocol (Real-Time PCR Analysis User Guide PN 68000088). The list of primers is provided in EV Table 4 . A total of 1.25ng of cDNA was preamplified using PreAmp Master Mix (Fluidigm, PN 100-5580, 100-5581, San Francisco, USA) in the plate thermal cycler at 95°C for 2min, 10 cycles at 95°C for 15sec and 60°C for 4min. The preamplified cDNA was treated by endonuclease I (New England BioLabs, PN M0293L, Massachusetts, USA) to remove unincorporated primers. The preamplified cDNA was mixed with 2x SsoFast EvaGreen Supermix (BioRad, PN 172-5211, California, USA), 50µM of mixed forward and reverse primers and sample Loading Reagent (Fluidigm, San Francisco, USA). The sample was loaded into the Dynamic Array 96.96 chip (Fluidigm San Francisco, USA). The qPCR reactions were performed in the BioMark RT PCR system. Data was analyzed using the BioMark RT-PCR Analysis Software Version 2.0.
Polysomal RNA preparation HL-1 cells were cultured in 150-mm dishes. 15 min prior to harversting, cells were treated by cycloheximide at 100 µg/ml. Cells were washed three times in PBS cold containing 100 µg/mL cycloheximide and scraped in the PBS/cycloheximide. After centrifugation at 3,000 rpm for 2 min at 4°C, cells were lysed by 450µl hypotonic lysis buffer (5 mM Tris-HCL, pH7.5 ; 2.5 mM MgCl2 ; 1.5 mM KCl). Cells were centrifuged at 13,000 rpm for 5 min at 4°C, the supernatants were collected and loaded onto a 10-50% sucrose gradient. The gradients were centrifuged in a Beckman SW40Ti rotor at 39,000 rpm for 2.5 h at 4°C without brake. Fractions were collected using a Foxy JR ISCO collector and UV optical unit type 11. RNA was purified from pooled heavy fractions containing polysomes, as well as from light fractions containing free RNA.
Preparation of biotinylated RNA
The FGF1, VEGFA or EMCV IRESs was cloned in pSCB-A-amp/kan plasmid (Agilent) downstream from the T7 sequence. The plasmid were linearized and in vitro transcription was performed with MEGAscript T7 kit (Ambion), according to the manufacturer's protocol, in the presence of Biotin-16-UTP at 1 mM (Roche), as previously described [25] . The synthesized RNA was purified using RNeasy kit (Qiagen).
BIA-MS experiments
BIA-MS studies based on surface plasmonic resonance (SPR) technology were performed on BIAcore T200 optical biosensor instrument (GE Healthcare), as described previously [12,25]. Immobilization of biotinylated IRES RNAs was performed on a streptavidin-coated (SA) sensorchip in HBS-EP buffer (10 mM Hepes pH 7.4, 150 mM NaCl, 3 mM EDTA, 0.005% surfactant P20) (GE Healthcare). All immobilization steps were performed at a flow rate of 2 µl/min with a final concentration of 100 µg/ml. Binding analyses were performed with normoxic or hypoxic cell protein extracts at 100 µg/ml over the immobilized IRES RNA surface for 120 sec at a flow rate of 30 µl/min. The channel (Fc1) was used as a reference surface for non-specific binding measurements. The recovery wizard was used to recover selected proteins from cell protein extracts. This step was carried out with 0.1% SDS. Five recovery procedures were performed to get enough amounts of proteins for MS identification. Eluted protein samples from BIA experiment were digested in gel with 1 µg of trypsin (sequence grade, Promega) at 37°C OVN. Peptides were then subjected to LC-MS/MS analysis. The peptides mixtures were loaded on a YMC-Triart C18 150x300 µm capillary column (particle diameter 3 µm) connected to a RS3000 Dionex HPLC system. The run length gradient (acetonitrile and water) was 30 minutes. Then, on the AB Sciex 5600+ mass spectrometer, data were acquired with a data dependent analysis. Data were then loaded on Mascot software (Matrix Science) that attributes peptide interpretations to MS/MS recorded scans.
Surface Plasmon Resonance assays.
For kinetic analysis, immobilization of biotinylated FGF1 IRES RNA was performed on a streptavidin-coated (SA) sensorchip in HBS-EP buffer (10 mM Hepes pH 7.4, 150 mM NaCl, 3mM EDTA, 0.005% surfactant P20) (GE Healthcare). Immobilization step was performed at a flow rate of 2 µl/min with a final concentration of 100 µg/ml. Total amount of immobilized FGF1 IRES RNA was 1500 RU. Binding analyses were performed with recombinant protein VASH1 (Abnova H00022846-P01) at 100 µg/ml over the immobilized FGF1. This recombinant VASH1 contains the 27 kDa Nterminal part of the protein coupled to glutathione S-transferase. The channel (Fc1) was used as a reference surface for non-specific binding measurements. A Single-Cycle Kinetics (SCK) analysis to determine association, dissociation and affinity constants (ka, kd, and KD respectively) was carried out by injecting different protein concentrations (16.25 nM-300 nM). Binding parameters were obtained by fitting the overlaid sensorgrams with the 1:1. Langmuir binding model of the BIAevaluation software version 3.0.
Immunocytology
Cells were plated on glass coverslip and incubated for 4 h of normoxia or hypoxia. They were fixed with cold methanol at -20°C during 5 min, washed 3 times with PBS and permeabilized 1 min with 0.1% Triton. Then, cells were incubated 5 min with blocking solution (1% FBS, 0.5% BSA) and 3° min with anti-VASH1 antibody (1/50; sc-365541) and Alexa 488 conjugated anti-mouse secondary antibody. Images were acquired with LSM780 Zeiss confocal microscope, camera lens x60 with Z acquisition of 0.36 µM. A single plan is shown Fig. 6C .
Statistical analysis
All statistical analyses were performed using a two-tailed Student's t-test or one-way ANOVA and are expressed as mean +-standard error of the mean, *p<0.05, **p<0.01, ***<0.001, ****<0.0001.
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The fully conserved monopartite NLS "HVLKKVKLG" identified in C and D has been positioned by a red box on the mouse and human peptide sequences shown in A and B, respectively. EV Table 1 . Transcriptome of (lymph)angiogenic factor genes in hypoxic HL-1 cardiomyocytes. Total RNA was purified from HL-1 cardiomyocytes submitted to increasing times from 5 min to 24 hr of hypoxia at 1% O2, as well as from normoxic cardiomyocytes as a control. cDNA was synthesized and used for a Fluidigm deltagene PCR array dedicated to genes related to (lymph)angiogenesis or stress (EV Table 4 ). Relative quantification (RQ) of gene expression in hypoxia was calculated using the 2 -ΔΔCT method with normalization to 18S and to normoxia. Standard deviation is indicated. When the RQ value is inferior to 1, the fold change is expressed as -1/RQ. ND means "non detected". Table 2 . Translatome of (lymph)angiogenic factor genes in hypoxic HL-1 and in VASH1 knockeddown HL-1 cardiomyocytes. Polysomes were purified on sucrose gradient from HL-1 cardiomyocytes in normoxia or after 4 h of hypoxia at 1% O2, or after treatment with siRNAs siControl and siVASH1 as described in Materials and Methods. RNA was purified from polysome-bound and free RNA. cDNA and PCR array was performed as in Figure 1 and in EV Table S1 . Relative quantification (RQ) of gene expression in hypoxia was calculated using the 2 -ΔΔCT method (polysomal RNA/free RNA normalized to normoxia). Standard deviation is indicated. When the RQ value is inferior to 1, the fold change is expressed as -1/RQ. ND means "non detected". 
